In 2000, Gwen Olson, the author of “Rx Drug Pusher,” walked away from the pharmaceutical industry, after spending 15 years selling drugs that she now admits are deadly. She states that there is “rampant economic incentive to over-prescribe drugs.”
Ms Olson left her job when her bosses wanted her to sell Celexa. In clinical studies, she says, the drug had been shown to increase the risk of suicidal thinking and behavior in children and adolescents who had depression.
She notes that other side effects of SSRIs are also more harmful to children because of their developing organs. “They are three times as likely to react to these drugs as an adult is,” she says.
According to Ms Olson, SSRIs alter the pathology of brain chemistry and are extremely addictive and she warns parents that once children get started on these drugs they may never get off and will end up being lifelong customers for the pharmaceutical industry.
After 15 years as a self-identified pusher for the pharmaceutical industry, it would probably be safe to assume that this lady knows what she is talking about.
By Evelyn Pringle
(This article is written as part of a series on Celexa related litigation and is sponsored by Robert Kwok & Associated, LLP)
(Evelyn Pringle is a regular columnist for OpEd News)